Zuranolone
Chemical compound
Nº Q48862264 ★★
Peu commune · Savoirs
Zuranolone
Chemical compound
Zuranolone, sold under the brand name Zurzuvae, is a medication used for the treatment of postpartum depression and major depressive disorder. It is taken orally.
Dernier prix
—
Prix plancher
—
Médiane 7 j
—
Ventes 30 j
0
Fourchette 30 j
—
En circulation
0
Cours
médiane
min – max
ventes
Aucune vente sur la période
Voir le tableau
| Date | médiane | Min | Max | ventes |
|---|
Historique des ventes
- Dernière vente
- —
- Moyenne 30 j
- —
- Plus bas 30 j
- —
- Plus haut 30 j
- —
- Ventes 7 j
- 0
- Ventes 30 j
- 0
Aucune vente pour l'instant.
Ventes anonymes : ni acheteur ni vendeur. Les chiffres ne comptent que les ventes entre joueurs.
Sur Wikipédia
Texte en anglais Pas encore d'article dans ta langue : extrait en anglais.
Zuranolone, sold under the brand name Zurzuvae, is a medication used for the treatment of postpartum depression and major depressive disorder. It is taken orally. Zuranolone is a neuroactive steroid which enhances the activity of the neurotransmitter γ-aminobutyric acid (GABA) and is thought to exert antidepressant effects by enhancing GABAergic inhibition. The most common side effects include drowsiness, dizziness, diarrhea, fatigue, nasopharyngitis, and urinary tract infection. Zuranolone was approved for medical use in the United States for the treatment of postpartum depression in August 2023. It was developed by Sage Therapeutics and Biogen.
Texte : Wikipédia en anglais, CC BY-SA 4.0. · Image : Ed (Edgar181) (Public domain) ·